Liquidia (LQDA): Buy the breakout or wait for pullback?
|Liquidia Corporation, (LQDA) is a biopharmaceutical company. It develops, manufactures & commercializes various products for unmet patient needs in the United States. It comes under Healthcare sector in Biotechnology Industry & trades as “LQDA” ticker at Nasdaq.
As discussed in last article, it extends rally in impulse I from June-2025 low. It should extend into $38.16 – $40.90 area to finish the wave ((5)) as I before correction start. We like to buy the pullback in 3, 7 or 11 swings at extreme area, when reach.
LQDA – Elliott Wave latest weekly view
In weekly, it broke the previous ATH from October-2018 in last rally & confirms bullish bias. It favors rally in I of (III) against June-2025 low. From August-2021 low, it placed I of (I) at $7.78 high, II at $4.06 low, III at $16.99 high, IV at $8.26 low & V at $19.41 high in May-2025. It corrected lower in (II) in 3 swings, which ended at $11.85 low in June-2025 low. Above (II) low, it placed ((1)) of I at $29.94 high, ((2)) at $21.15 low, ((3)) at $36.41 high, ((4)) at $29.30 low & favors rally in ((5)).
LQDA – Elliott Wave view from 8.25.2025
Within ((1)), it ended (1) at $20.33 high, (2) at $16.82 low, (3) at $28.82 high (4) at $26.06 low & (5) at $29.94 high. Within ((3)), it placed (1) at $25.12 high, (2) at $21.94 low, (3) at $35.54 high, (4) at $32.11 low & (5) at $36.41 high. Currently, it favors rally in (1) of ((5)) & expect minor high before correcting in (2). As long as it stays above $29.30 low of 1.05.2026, it should extend higher in 5 swings to finish ((5)). The ((5)) expects to extend into $38.16 – $40.90 area to finish I impulse before correcting next. It already reached the minimum area, so if it breaks below $29.30 low, it can be II as alternate view. We like to buy the pullback in 3, 7 or 11 swings in II against June-2025 low. If it managed to erase the momentum divergence, then it can be nesting in I.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.